 Shares of Wave Life Sciences Ltd. WVE, -7.20 jumped about 17 in premarket trading on Tuesday after the company announced a four-year strategic collaboration with GlaxoSmithKline GSK, -0.72 to develop oligonucleotide therapeutics. 